Page last updated: 2024-08-24

gallocatechol and Disease Exacerbation

gallocatechol has been researched along with Disease Exacerbation in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's0 (0.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Choudhry, F; Cox, CJ; Francis, PT; Howlett, DR; Lichtenthaler, SF; Peacey, E; Perkinton, MS; Richardson, JC; Williams, RJ1
Ghosh, B; Pusp, P; Roy, S; Sannigrahi, S; Vaddepalli, RP1
Dickinson, D; Fu, B; Hsu, S; Jiang, J; Pearl, H; Zhao, M; Zheng, R1
Agarwal, R; Katiyar, SK; Mohan, RR; Mukhtar, H1

Other Studies

4 other study(ies) available for gallocatechol and Disease Exacerbation

ArticleYear
Dietary (-)-epicatechin as a potent inhibitor of βγ-secretase amyloid precursor protein processing.
    Neurobiology of aging, 2015, Volume: 36, Issue:1

    Topics: Administration, Oral; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Brain; Catechin; Cells, Cultured; Disease Progression; Male; Mice, Transgenic

2015
A novel combination of methotrexate and epigallocatechin attenuates the overexpression of pro-inflammatory cartilage cytokines and modulates antioxidant status in adjuvant arthritic rats.
    Inflammation, 2012, Volume: 35, Issue:4

    Topics: Animals; Arthritis, Experimental; Catalase; Catechin; Disease Progression; Drug Combinations; Glutathione; Interleukin-6; Lipid Peroxidation; Male; Methotrexate; Mycobacterium; Rats; Rats, Sprague-Dawley; Superoxide Dismutase; Tumor Necrosis Factor-alpha

2012
A proprietary topical preparation containing EGCG-stearate and glycerin with inhibitory effects on herpes simplex virus: case study.
    Inflammation & allergy drug targets, 2012, Volume: 11, Issue:5

    Topics: Administration, Topical; Adult; Catechin; Disease Progression; Disease-Free Survival; Female; Glycerol; Herpes Labialis; Humans; Male; Simplexvirus; Stearates

2012
Protection against induction of mouse skin papillomas with low and high risk of conversion to malignancy by green tea polyphenols.
    Carcinogenesis, 1997, Volume: 18, Issue:3

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anticarcinogenic Agents; Antioxidants; Carcinoma, Squamous Cell; Catechin; Cocarcinogenesis; Disease Progression; Diterpenes; Flavonoids; Mice; Mice, Inbred SENCAR; Papilloma; Phenols; Plant Extracts; Polymers; Skin Neoplasms; Tea; Terpenes

1997